Status:
COMPLETED
Does Notch Regulate Glioma Proliferation ?
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Glioma
Eligibility:
All Genders
18+ years
Brief Summary
The investigators showed in 2015 (Guichet et al) that the Notch1 pathway has an anti-proliferative role on glial brain tumors. In this project, the investigators investigated which genes downstream of...
Detailed Description
Main objectives: To examine the expression of TAL1 and SNAI2 in protein extracts and glioma sections of different grades (glioblastomas and diffuse low-grade tumors). To examine the effect of overex...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patient ≥18 years old
- Patient affected with brain glioma classified according to WHO 2016 classification
- Exclusion Criteria:
- Patient who reject the study protocol
- Radiotheray or chemotherapy treatment
Exclusion
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 20 2021
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04809597
Start Date
January 1 2012
End Date
January 20 2021
Last Update
March 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295